120 related articles for article (PubMed ID: 25618333)
1. Applying the logic of genetic interaction to discover small molecules that functionally interact with human disease alleles.
Brettman AD; Tan PH; Tran K; Shaw SY
Methods Mol Biol; 2015; 1263():15-27. PubMed ID: 25618333
[TBL] [Abstract][Full Text] [Related]
2. Predicting bioprocess targets of chemical compounds through integration of chemical-genetic and genetic interactions.
Simpkins SW; Nelson J; Deshpande R; Li SC; Piotrowski JS; Wilson EH; Gebre AA; Safizadeh H; Okamoto R; Yoshimura M; Costanzo M; Yashiroda Y; Ohya Y; Osada H; Yoshida M; Boone C; Myers CL
PLoS Comput Biol; 2018 Oct; 14(10):e1006532. PubMed ID: 30376562
[TBL] [Abstract][Full Text] [Related]
3. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
Goldman RC
Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
[TBL] [Abstract][Full Text] [Related]
4. Array-based synthetic genetic screens to map bacterial pathways and functional networks in Escherichia coli.
Babu M; Gagarinova A; Emili A
Methods Mol Biol; 2011; 781():99-126. PubMed ID: 21877280
[TBL] [Abstract][Full Text] [Related]
5. Application of chemical biology in target identification and drug discovery.
Zhu Y; Xiao T; Lei S; Zhou F; Wang MW
Arch Pharm Res; 2015 Sep; 38(9):1642-50. PubMed ID: 26242900
[TBL] [Abstract][Full Text] [Related]
6. Chemical genomics approaches in plant biology.
Norambuena L; Raikhel NV; Hicks GR
Methods Mol Biol; 2009; 553():345-54. PubMed ID: 19588115
[TBL] [Abstract][Full Text] [Related]
7. Biodiversity of small molecules--a new perspective in screening set selection.
Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
[TBL] [Abstract][Full Text] [Related]
8. Determining the mode of action of bioactive compounds.
Azad MA; Wright GD
Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
[TBL] [Abstract][Full Text] [Related]
9. Target identification of small molecules based on chemical biology approaches.
Futamura Y; Muroi M; Osada H
Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
[TBL] [Abstract][Full Text] [Related]
10. The Role of Historical Bioactivity Data in the Deconvolution of Phenotypic Screens.
Bornot A; Blackett C; Engkvist O; Murray C; Bendtsen C
J Biomol Screen; 2014 Jun; 19(5):696-706. PubMed ID: 24441646
[TBL] [Abstract][Full Text] [Related]
11. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
12. Large-scale bioactivity analysis of the small-molecule assayed proteome.
Backman TW; Evans DS; Girke T
PLoS One; 2017; 12(2):e0171413. PubMed ID: 28178331
[TBL] [Abstract][Full Text] [Related]
13. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
15. Lead identification to clinical candidate selection: drugs for Chagas disease.
Neitz RJ; Chen S; Supek F; Yeh V; Kellar D; Gut J; Bryant C; Gallardo-Godoy A; Molteni V; Roach SL; Khare S; Stinson M; Chatterjee AK; Robertson S; Renslo AR; Arkin M; Glynne R; McKerrow J; Siqueira-Neto JL
J Biomol Screen; 2015 Jan; 20(1):101-11. PubMed ID: 25281737
[TBL] [Abstract][Full Text] [Related]
16. Parsimonious discovery of synergistic drug combinations.
Severyn B; Liehr RA; Wolicki A; Nguyen KH; Hudak EM; Ferrer M; Caldwell JS; Hermes JD; Li J; Tudor M
ACS Chem Biol; 2011 Dec; 6(12):1391-8. PubMed ID: 21974780
[TBL] [Abstract][Full Text] [Related]
17. Designing zebrafish chemical screens.
Peterson RT; Fishman MC
Methods Cell Biol; 2011; 105():525-41. PubMed ID: 21951546
[TBL] [Abstract][Full Text] [Related]
18. Identification of small-molecule modulators of the circadian clock.
Hirota T; Kay SA
Methods Enzymol; 2015; 551():267-82. PubMed ID: 25662461
[TBL] [Abstract][Full Text] [Related]
19. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
Zhu Z; Cuozzo J
J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
[TBL] [Abstract][Full Text] [Related]
20. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
